Your browser doesn't support javascript.
loading
Safety and superior immunogenicity of heterologous boosting with an RBD-based SARS-CoV-2 mRNA vaccine in Chinese adults.
Liu, Xiaoqiang; Li, Yuhua; Wang, Zhongfang; Cao, Shouchun; Huang, Weijin; Yuan, Lin; Huang, Yi-Jiao; Zheng, Yan; Chen, Jingjing; Ying, Bo; Xiang, Zuoyun; Shi, Jin; Zhao, Jincun; Huang, Zhen; Qin, Cheng-Feng.
Afiliação
  • Liu X; Yunnan Province Centre for Disease Control and Prevention, Kunming, Yunnan, China.
  • Li Y; National Institutes for Food and Drug Control, Beijing, China.
  • Wang Z; Respiratory Medicine, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong, China.
  • Cao S; National Institutes for Food and Drug Control, Beijing, China.
  • Huang W; National Institutes for Food and Drug Control, Beijing, China.
  • Yuan L; Walvax Biotechnology Co., Ltd., Kunming, Yunnan, China.
  • Huang YJ; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China.
  • Zheng Y; Yunnan Province Centre for Disease Control and Prevention, Kunming, Yunnan, China.
  • Chen J; Walvax Biotechnology Co., Ltd., Kunming, Yunnan, China.
  • Ying B; Suzhou Abogen Biosciences Co., Ltd, Suzhou, Jiangsu, China.
  • Xiang Z; Walvax Biotechnology Co., Ltd., Kunming, Yunnan, China.
  • Shi J; Walvax Biotechnology Co., Ltd., Kunming, Yunnan, China.
  • Zhao J; Respiratory Medicine, Guangzhou Institute of Respiratory Health, Guangzhou, Guangdong, China. zhaojincun@gird.cn.
  • Huang Z; Walvax Biotechnology Co., Ltd., Kunming, Yunnan, China. hz@walvax.com.
  • Qin CF; State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, Beijing, China. qincf@bmi.ac.cn.
Cell Res ; 32(8): 777-780, 2022 08.
Article em En | MEDLINE | ID: mdl-35701541
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Revista: Cell Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Limite: Adult / Humans País/Região como assunto: Asia Idioma: En Revista: Cell Res Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China